Get started Log in

HLVX — HilleVax Share News

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Brief: Hillevax Reports Third Quarter 2022 Financial Results And Highlights Recent Company Progress
10/11/2022 21:21
HilleVax rises on resumption of gastroenteritis vaccine study
31/08/2022 18:32
Brief: Hillevax Announces Positive Recommendation From Safety Data Monitoring Committee For Mid-stage Trial Of Hil-214 Norovirus Vaccine Candidate
31/08/2022 12:22
Brief: Hillevax Inc QTRLY Loss Per Share $2.03
10/08/2022 21:56
Brief: Hillevax Announces Results From 5-Year Clinical Study
20/07/2022 22:00
Brief: HilleVax Reports First Quarter 2022 Financial Results And Highlights Recent Company Progress
08/06/2022 21:03
U.S. RESEARCH ROUNDUP-Alphabet, JP Morgan, Tesla
24/05/2022 08:22
Factbox: New U.S. stock listings fail to impress in turbulent 2022
06/05/2022 17:36
Brief: Hillevax Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters’ Option To Purchase Additional Shares
03/05/2022 22:39
HilleVax gains after starting norovirus vaccine trial
02/05/2022 19:13
Brief: Hillevax Announces Initiation Of Phase 2B Clinical Trial Of Hil-214 Vaccine Candidate For Prevention Of Acute Gastroenteritis In Infants
02/05/2022 13:18
NASDAQ RESUMED AT 11:49 AM
29/04/2022 16:49
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:59 AM
29/04/2022 08:59
Brief: Hillevax Announces Pricing Of Upsized Initial Public Offering
29/04/2022 02:05